10-Q · 2026-11-16
Neumora Therapeutics has announced its Q3 results, showcasing advancements in clinical programs and financial stability in the biological products sector.
| Name | Neumora Therapeutics, Inc. |
|---|---|
| CIK | 0001885522 |
| Tickers | NMRA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 844367680 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (857) 760-0900 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Neumora Therapeutics has announced its Q3 results, showcasing advancements in clinical programs and financial stability in the biological products sector.
Neumora Therapeutics, Inc. announces its third-quarter financial results, showcasing its progress in the biological products industry.
261 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-463633 | 005-94162 | 261561699 | 34 | 6974 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462194 | 001-41802 | 261555606 | 34 | 10595169 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-462165 | 001-41802 | 261555556 | 34 | 355359 | 1 | 1 |
| 2026-10-30 | 8-K | 8-K | 3.01 | 0001193125-26-441634 | 001-41802 | 261508015 | 34 | 139199 | 1 | 1 |
| 2026-08-21 | 4 | FORM 4 | 0001610717-26-000385 | 32359 | ||||||
| 2026-08-21 | 4 | FORM 4 | 0001610717-26-000384 | 5788 | ||||||
| 2026-08-21 | 4 | FORM 4 | 0001610717-26-000383 | 5798 | ||||||
| 2026-08-21 | 4 | FORM 4 | 0001610717-26-000382 | 5796 | ||||||
| 2026-08-21 | 4 | FORM 4 | 0001610717-26-000381 | 5735 | ||||||
| 2026-08-21 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000408 | 001-41802 | 261305179 | 33 | 6922 | |||
| 2026-08-20 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000403 | 001-41802 | 261300170 | 33 | 6283 | |||
| 2026-08-19 | 4 | FORM 4 | 0001610717-26-000362 | 57618 | ||||||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000401 | 001-41802 | 261295428 | 33 | 5641 | |||
| 2026-08-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000400 | 001-41802 | 261291326 | 33 | 5001 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000398 | 001-41802 | 261287683 | 33 | 5633 | |||
| 2026-08-14 | 10-Q | 10-Q | 0001193125-26-350370 | 001-41802 | 261276057 | 34 | 9817042 | 1 | 1 | |
| 2026-08-14 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-26-350349 | 001-41802 | 261276032 | 34 | 345443 | 1 | 1 |
| 2026-07-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-316819 | 001-41802 | 261202804 | 34 | 248928 | 1 | 1 |
| 2026-06-15 | 8-K | 8-K | 1.01,2.03,2.05,7.01,8.01,9.01 | 0001193125-26-270328 | 001-41802 | 261089123 | 34 | 185957 | 1 | 1 |
| 2026-05-29 | 4 | xslF345X06/form4.xml | 0001610717-26-000174 | 5351 | ||||||
| 2026-05-29 | 4 | xslF345X06/form4.xml | 0001610717-26-000173 | 5339 | ||||||
| 2026-05-29 | 4 | xslF345X06/form4.xml | 0001610717-26-000171 | 5346 | ||||||
| 2026-05-29 | 4 | xslF345X06/form4.xml | 0001610717-26-000170 | 5337 | ||||||
| 2026-05-29 | 4 | xslF345X06/form4.xml | 0001610717-26-000169 | 5322 | ||||||
| 2026-05-29 | 8-K | 8-K | 5.07 | 0001193125-26-248244 | 001-41802 | 261044292 | 34 | 150238 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-002417 | 005-94162 | 26989791 | 34 | 11329 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-211825 | 001-41802 | 26952961 | 34 | 8786163 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210310 | 001-41802 | 26950825 | 34 | 283804 | 1 | 1 |
| 2026-05-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002005369-26-000023 | 005-94162 | 26936530 | 34 | 18650 | |||
| 2026-04-17 | DEFA14A | DEFA14A | 0001193125-26-161519 | 001-41802 | 26871549 | 34 | 819307 | |||
| 2026-04-17 | DEF 14A | DEF 14A | 0001193125-26-161489 | 001-41802 | 26871490 | 34 | 3966909 | 1 | 1 | |
| 2026-04-01 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001012975-26-000294 | 005-94162 | 26828225 | 34 | 35645 | |||
| 2026-03-30 | S-8 | S-8 | 0001193125-26-130407 | 333-294723 | 26809964 | 33 | 445560 | 1 | 1 | |
| 2026-03-30 | 10-K | 10-K | 0001193125-26-130388 | 001-41802 | 26809946 | 34 | 13730047 | 1 | 1 | |
| 2026-03-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-130372 | 001-41802 | 26809923 | 34 | 362202 | 1 | 1 |
| 2026-02-19 | 4 | xslF345X05/form4.xml | 0001610717-26-000054 | 4674 | ||||||
| 2026-02-19 | 4 | xslF345X05/form4.xml | 0001610717-26-000053 | 5387 | ||||||
| 2026-02-19 | 4 | xslF345X05/form4.xml | 0001610717-26-000052 | 7663 | ||||||
| 2026-02-19 | 4 | xslF345X05/form4.xml | 0001610717-26-000051 | 4872 | ||||||
| 2026-02-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002005369-26-000014 | 005-94162 | 26655070 | 34 | 25087 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000905148-26-000895 | 005-94162 | 26642673 | 34 | 11432 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000112 | 001-41802 | 26641996 | 33 | 4396 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000111 | 001-41802 | 26641958 | 33 | 4394 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000110 | 001-41802 | 26641864 | 33 | 4417 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-26-000109 | 001-41802 | 26641815 | 33 | 4524 | |||
| 2026-02-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-045526 | 001-41802 | 26618325 | 34 | 6674671 | 1 | 1 |
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-009727 | 001-41802 | 26524615 | 34 | 5195612 | 1 | 1 |
| 2026-01-09 | 4 | xslF345X05/form4.xml | 0001610717-26-000014 | 5499 | ||||||
| 2026-01-09 | 4 | xslF345X05/form4.xml | 0001610717-26-000011 | 5519 | ||||||
| 2026-01-09 | 4 | xslF345X05/form4.xml | 0001610717-26-000010 | 5497 | ||||||
| 2026-01-09 | 4 | xslF345X05/form4.xml | 0001610717-26-000009 | 5428 | ||||||
| 2026-01-09 | 4 | xslF345X05/form4.xml | 0001610717-26-000008 | 5554 | ||||||
| 2026-01-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-001472 | 001-41802 | 26503859 | 34 | 196477 | 1 | 1 |
| 2025-11-21 | 8-K | 8-K | 3.02,9.01 | 0001193125-25-291352 | 001-41802 | 251507916 | 34 | 140014 | 1 | 1 |
| 2025-11-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000378 | 6012 | ||||||
| 2025-11-12 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-051788 | 001-41802 | 251474962 | 33 | 4600 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269446 | 001-41802 | 251458093 | 34 | 15730132 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-268046 | 001-41802 | 251456095 | 34 | 369097 | 1 | 1 |
| 2025-10-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000681 | 11907 | ||||||
| 2025-10-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000680 | 21270 | ||||||
| 2025-10-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000679 | 27718 | ||||||
| 2025-10-29 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001012975-25-000675 | 005-94162 | 251431600 | 34 | 36025 | |||
| 2025-10-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-250677 | 001-41802 | 251417431 | 34 | 209003 | 1 | 1 |
| 2025-10-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-250656 | 001-41802 | 251417368 | 34 | 212062 | 1 | 1 |
| 2025-08-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000905148-25-002815 | 005-94162 | 251202746 | 34 | 16868 | |||
| 2025-08-06 | 10-Q | 10-Q | 0000950170-25-104138 | 001-41802 | 251190150 | 34 | 16335047 | 1 | 1 | |
| 2025-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-103997 | 001-41802 | 251189534 | 34 | 396434 | 1 | 1 |
| 2025-05-30 | 4 | 4 | 0000950170-25-079926 | 26174 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079924 | 12792 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079925 | 18476 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079923 | 14614 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079922 | 39643 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079921 | 14626 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079920 | 21699 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079919 | 18232 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079918 | 14517 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079908 | 34826 | ||||||
| 2025-05-30 | 8-K | 8-K | 5.07 | 0001193125-25-132307 | 001-41802 | 251012298 | 34 | 150082 | 1 | 1 |
| 2025-05-23 | 4 | xslF345X05/form4.xml | 0001610717-25-000128 | 6439 | ||||||
| 2025-05-16 | DEFA14A | DEFA14A | 0001193125-25-121717 | 001-41802 | 25959716 | 34 | 28180 | |||
| 2025-05-16 | 8-K | 8-K | 3.01 | 0001193125-25-121714 | 001-41802 | 25959698 | 34 | 148147 | 1 | 1 |
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069311 | 001-41802 | 25935417 | 34 | 13952560 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-069147 | 001-41802 | 25934663 | 34 | 330323 | 1 | 1 |
| 2025-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001531 | 005-94162 | 25933277 | 34 | 11360 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0000950170-25-060098 | 001-41802 | 25887177 | 34 | 682244 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0000950170-25-060084 | 001-41802 | 25887053 | 34 | 2607507 | 1 | 1 | |
| 2025-04-11 | PRE 14A | PRE 14A | 0000950170-25-053346 | 001-41802 | 25832831 | 34 | 2579417 | 1 | 1 | |
| 2025-04-11 | 8-K/A | 8-K/A | 5.02 | 0000950170-25-053303 | 001-41802 | 25832542 | 34 | 157467 | 1 | 1 |
| 2025-03-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000791 | 333-282460 | 25774972 | 33 | 1863 | ||
| 2025-03-12 | 144 | xsl144X01/primary_doc.xml | 0001968582-25-000180 | 001-41802 | 25732381 | 33 | 4535 | |||
| 2025-03-03 | S-8 | S-8 | 0001193125-25-044187 | 333-285507 | 25698785 | 33 | 256406 | 1 | 1 | |
| 2025-03-03 | POS AM | POS AM | 0001193125-25-044183 | 333-282460 | 25698729 | 33 | 445006 | |||
| 2025-03-03 | 10-K | 10-K | 0000950170-25-030401 | 001-41802 | 25693791 | 34 | 20603108 | 1 | 1 | |
| 2025-03-03 | POSASR | POSASR | 0001193125-25-043400 | 333-282460 | 25693756 | 33 | 515758 | |||
| 2025-03-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-030396 | 001-41802 | 25693740 | 34 | 376486 | 1 | 1 |
| 2025-02-21 | 8-K/A | 8-K/A | 5.02 | 0001193125-25-031974 | 001-41802 | 25651590 | 34 | 153524 | 1 | 1 |
| 2025-02-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000031 | 7853 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000030 | 5422 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000029 | 6181 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000028 | 5361 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000027 | 6198 | ||||||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000081 | 001-41802 | 25636432 | 33 | 4396 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000080 | 001-41802 | 25636416 | 33 | 4527 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000079 | 001-41802 | 25636390 | 33 | 4508 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000078 | 001-41802 | 25636372 | 33 | 4510 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000077 | 001-41802 | 25636356 | 33 | 4431 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000076 | 001-41802 | 25636345 | 33 | 4471 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-25-000075 | 001-41802 | 25636330 | 33 | 4516 | |||
| 2025-02-18 | 4 | 4 | 0000950170-25-022323 | 20042 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022327 | 16566 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022322 | 13073 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022320 | 37926 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022326 | 16583 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022321 | 12733 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022317 | 12721 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022325 | 24461 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022319 | 33111 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022316 | 11079 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022318 | 12764 | ||||||
| 2025-02-13 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-25-026156 | 001-41802 | 25621176 | 34 | 184163 | 1 | 1 |
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-019939 | 005-94162 | 25620745 | 34 | 7061 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-004999 | 001-41802 | 25524861 | 34 | 4261351 | 1 | 1 |
| 2025-01-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-000084 | 001-41802 | 25500214 | 34 | 185422 | 1 | 1 |
| 2024-12-27 | 4 | xslF345X05/form4.xml | 0001610717-24-000555 | 9890 | ||||||
| 2024-11-22 | SC 13D/A | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#2) | 0001072613-24-000899 | 005-94162 | 241491098 | 34 | 648355 | |||
| 2024-11-12 | SC 13G | formsc13g.htm | 0001493152-24-044786 | 005-94162 | 241448895 | 34 | 227455 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125437 | 001-41802 | 241448407 | 34 | 10407200 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-124563 | 001-41802 | 241443257 | 34 | 303227 | 1 | 1 |
| 2024-10-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000511 | 23999 | ||||||
| 2024-10-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000383 | 001-41802 | 241380736 | 33 | 5088 | |||
| 2024-10-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000382 | 001-41802 | 241377879 | 33 | 4490 | |||
| 2024-10-11 | 4 | xslF345X05/form4.xml | 0001610717-24-000505 | 7083 | ||||||
| 2024-10-10 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000376 | 001-41802 | 241365551 | 33 | 7043 | |||
| 2024-10-09 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000375 | 001-41802 | 241362883 | 33 | 6412 | |||
| 2024-10-01 | S-3ASR | S-3ASR | 0001193125-24-230348 | 333-282460 | 241344451 | 33 | 1388518 | |||
| 2024-09-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000490 | 7085 | ||||||
| 2024-09-18 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000364 | 001-41802 | 241307888 | 33 | 5784 | |||
| 2024-09-17 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000363 | 001-41802 | 241304943 | 33 | 5151 | |||
| 2024-09-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000478 | 5220 | ||||||
| 2024-09-13 | 4 | xslF345X05/form4.xml | 0001610717-24-000475 | 18859 | ||||||
| 2024-09-12 | 144 | xsl144X01/primary_doc.xml | 0001964306-24-000357 | 001-41802 | 241295776 | 33 | 4410 | |||
| 2024-08-27 | 4 | xslF345X05/form4.xml | 0001610717-24-000457 | 5872 | ||||||
| 2024-08-26 | 4 | xslF345X05/form4.xml | 0001610717-24-000456 | 9941 | ||||||
| 2024-08-22 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000259 | 001-41802 | 241230405 | 33 | 4411 | |||
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091737 | 001-41802 | 241179008 | 34 | 9216496 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-091205 | 001-41802 | 241177073 | 34 | 303463 | 1 | 1 |
| 2024-07-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-24-001797 | 005-94162 | 241104907 | 34 | 11133 | |||
| 2024-07-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-24-001795 | 005-94162 | 241104011 | 34 | 8689 | |||
| 2024-06-28 | 4 | xslF345X05/form4.xml | 0001610717-24-000380 | 5836 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000338 | 7013 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000337 | 6998 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000336 | 7028 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000335 | 7030 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000334 | 14825 | ||||||
| 2024-06-14 | 8-K | 8-K | 5.07 | 0001193125-24-161572 | 001-41802 | 241044592 | 34 | 156501 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-054448 | 001-41802 | 24921653 | 34 | 9794175 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-053933 | 001-41802 | 24919592 | 34 | 256364 | 1 | 1 |
| 2024-04-25 | DEFA14A | DEFA14A | 0000950170-24-048333 | 001-41802 | 24876484 | 34 | 262620 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0000950170-24-048287 | 001-41802 | 24876176 | 34 | 1006399 | |||
| 2024-04-24 | 4 | xslF345X05/form4.xml | 0001610717-24-000222 | 5515 | ||||||
| 2024-04-15 | 8-K | 8-K | 8.01 | 0001193125-24-095472 | 001-41802 | 24843071 | 34 | 147333 | 1 | 1 |
| 2024-03-07 | S-8 | S-8 | 0001193125-24-062239 | 333-277748 | 24730678 | 33 | 95390 | |||
| 2024-03-07 | 10-K | 10-K | 0000950170-24-027927 | 001-41802 | 24730051 | 34 | 12821279 | 1 | 1 | |
| 2024-03-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-061473 | 001-41802 | 24728136 | 34 | 227360 | 1 | 1 |
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000069 | 7280 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000068 | 7331 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000067 | 7318 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000066 | 7221 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000065 | 9043 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000064 | 7404 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0001610717-24-000063 | 7316 | ||||||
| 2024-02-14 | SC 13G | SC 13G | 0001193125-24-036256 | 005-94162 | 24638580 | 34 | 46180 | |||
| 2024-02-13 | SC 13G | formsc13g.htm | 0001493152-24-006168 | 005-94162 | 24627564 | 34 | 254781 | |||
| 2024-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-003968 | 001-41802 | 24518502 | 34 | 10695689 | 1 | 1 |
| 2023-12-15 | SC 13D/A | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1) | 0001072613-23-000627 | 005-94162 | 231491247 | 34 | 658052 | |||
| 2023-12-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022481 | 22441 | ||||||
| 2023-12-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022480 | 28790 | ||||||
| 2023-12-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022479 | 14005 | ||||||
| 2023-12-12 | 4 | xslF345X05/form4.xml | 0001610717-23-000398 | 5365 | ||||||
| 2023-12-12 | 3 | xslF345X02/form3.xml | 0001610717-23-000397 | 10298 | ||||||
| 2023-11-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-284303 | 001-41802 | 231446747 | 34 | 148604 | 1 | 1 |
| 2023-11-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020934 | 8764 | ||||||
| 2023-11-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020933 | 16387 | ||||||
| 2023-11-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020714 | 14285 | ||||||
| 2023-11-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020712 | 21908 | ||||||
| 2023-11-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020280 | 10599 | ||||||
| 2023-11-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020279 | 18222 | ||||||
| 2023-11-01 | 10-Q | 10-Q | 0000950170-23-057424 | 001-41802 | 231368195 | 34 | 9891737 | 1 | 1 | |
| 2023-11-01 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-268165 | 001-41802 | 231368093 | 34 | 235917 | 1 | 1 |
| 2023-10-02 | SC 13D | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D | 0001072613-23-000508 | 005-94162 | 231297318 | 34 | 662823 | |||
| 2023-09-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018633 | 10599 | ||||||
| 2023-09-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018632 | 18222 | ||||||
| 2023-09-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018548 | 8760 | ||||||
| 2023-09-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018547 | 16383 | ||||||
| 2023-09-27 | SC 13D | SC 13D | 0001193125-23-243053 | 005-94162 | 231281818 | 34 | 113104 | |||
| 2023-09-25 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018469 | 18223 | ||||||
| 2023-09-25 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018468 | 10599 | ||||||
| 2023-09-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-050240 | 21985 | ||||||
| 2023-09-20 | 4 | xslF345X05/form4.xml | 0001610717-23-000291 | 30918 | ||||||
| 2023-09-20 | 4 | FORM 4 SUBMISSION | 0000899243-23-019274 | 41084 | ||||||
| 2023-09-20 | 4 | FORM 4 SUBMISSION | 0000899243-23-019273 | 45036 | ||||||
| 2023-09-20 | S-8 | S-8 | 0001193125-23-237903 | 333-274593 | 231265202 | 33 | 477752 | |||
| 2023-09-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000290 | 6586 | ||||||
| 2023-09-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000289 | 10296 | ||||||
| 2023-09-19 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-23-237644 | 001-41802 | 231263999 | 34 | 438391 | 1 | 1 |
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000286 | 7133 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000285 | 5203 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000284 | 5218 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000283 | 5234 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000282 | 5144 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001610717-23-000281 | 5127 | ||||||
| 2023-09-18 | 424B4 | 424B4 | 0001193125-23-236920 | 333-274229 | 231261315 | 33 | 3770836 | |||
| 2023-09-18 | 3 | FORM 3 SUBMISSION | 0000899243-23-019226 | 13460 | ||||||
| 2023-09-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-09-14 16:00:00 | 9999999995-23-002676 | 333-274229 | 231260019 | 33 | 1809 | ||
| 2023-09-14 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004194 | 63737 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019101 | 43784 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019099 | 47745 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019093 | 21405 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019084 | 8064 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019082 | 13408 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019081 | 8138 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019080 | 8043 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019079 | 9692 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019078 | 14738 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0001209191-23-049494 | 10829 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019074 | 12986 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019071 | 6175 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019070 | 11407 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019068 | 11908 | ||||||
| 2023-09-14 | 3 | FORM 3 SUBMISSION | 0000899243-23-019063 | 15979 | ||||||
| 2023-09-14 | CERT | 8A_cert_NMRA.pdf | 0001354457-23-000670 | 001-41802 | 231254771 | 34 | 183981 | |||
| 2023-09-13 | 8-A12B | 8-A12B | 0001193125-23-234448 | 001-41802 | 231253317 | 34 | 14650 | |||
| 2023-09-12 | CORRESP | filename1.htm | 0001193125-23-233465 | 7682 | ||||||
| 2023-09-12 | CORRESP | filename1.htm | 0001193125-23-233460 | 8829 | ||||||
| 2023-09-11 | S-1/A | S-1/A | 0001193125-23-231902 | 333-274229 | 231246590 | 33 | 5255187 | |||
| 2023-08-25 | CORRESP | filename1.htm | 0001193125-23-221597 | 39260 | ||||||
| 2023-08-25 | S-1 | S-1 | 0001193125-23-221589 | 333-274229 | 231209169 | 33 | 8034745 | |||
| 2023-08-17 | UPLOAD | filename1.pdf | 0000000000-23-009015 | 43954 | ||||||
| 2023-08-09 | DRS/A | filename1.htm | 0000950123-23-006927 | 377-05663 | 231153157 | 33 | 4098117 | |||
| 2023-08-08 | DRSLTR | filename1.htm | 0000950123-23-006930 | 37480 | ||||||
| 2023-07-12 | UPLOAD | filename1.pdf | 0000000000-23-007447 | 45532 | ||||||
| 2023-06-30 | DRSLTR | filename1.htm | 0000950123-23-005917 | 41932 | ||||||
| 2023-06-30 | DRS/A | filename1.htm | 0000950123-23-005916 | 377-05663 | 231062495 | 33 | 4624820 | |||
| 2023-05-24 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-002978 | 64898 | ||||||
| 2023-05-24 | UPLOAD | filename1.pdf | 0000000000-23-005549 | 52885 | ||||||
| 2023-05-02 | DRS/A | filename1.htm | 0000950123-23-003601 | 377-05663 | 23880485 | 33 | 3302946 | |||
| 2023-01-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-23-000019 | 021-469477 | 23501653 | 33 | 12129 | ||
| 2022-09-02 | DRSLTR | filename1.htm | 0000950123-22-009779 | 29792 | ||||||
| 2022-09-02 | DRS/A | filename1.htm | 0000950123-22-009778 | 377-05663 | 221226165 | 33 | 4769569 | |||
| 2022-06-17 | UPLOAD | filename1.pdf | 0000000000-22-006617 | 43993 | ||||||
| 2022-06-10 | DRSLTR | filename1.htm | 0000950123-22-006852 | 33424 | ||||||
| 2022-06-10 | DRS/A | filename1.htm | 0000950123-22-006850 | 377-05663 | 221009931 | 33 | 4743066 | |||
| 2022-05-16 | UPLOAD | filename1.pdf | 0000000000-22-005312 | 48026 | ||||||
| 2022-05-02 | DRS/A | filename1.htm | 0000950123-22-004443 | 377-05663 | 22882861 | 33 | 4464638 | |||
| 2022-02-14 | DRS/A | filename1.htm | 0000950123-22-002276 | 377-05663 | 22624314 | 33 | 5441045 | |||
| 2022-02-11 | DRSLTR | filename1.htm | 0000950123-22-002278 | 26877 | ||||||
| 2022-01-07 | UPLOAD | filename1.pdf | 0000000000-22-000215 | 44164 | ||||||
| 2021-12-23 | DRS/A | filename1.htm | 0000950123-21-016457 | 377-05663 | 211514185 | 33 | 4533664 | |||
| 2021-12-22 | DRSLTR | filename1.htm | 0000950123-21-016461 | 57752 | ||||||
| 2021-12-06 | UPLOAD | filename1.pdf | 0000000000-21-014636 | 61135 | ||||||
| 2021-11-08 | DRS | filename1.htm | 0000950123-21-014224 | 377-05663 | 211388837 | 33 | 3713114 |
One latest value per concept from companyfacts (208 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 188.69M | 2026-11-11 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 63.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 407,407 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161489 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 5.02M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161489 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 10.5 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161489 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AccretionExpense | Accretion Expense | USD | 791,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 20.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 991,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 187,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 62,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.33B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 6.14M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 20.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 410,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 39.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | Assets | Assets | USD | 95.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 94.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 290.66M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedGain | Debt Securities, Available-for-sale, Unrealized Gain | USD | 70,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 8,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 239.79M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054448 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 290.72M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 44,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 85.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 85.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -96.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 57.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 700.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 174.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 174.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 19,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -130.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 843.69M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 130,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 130,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 58.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 4.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 1.00M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269446 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 105,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 330.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 87.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 105,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 164.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 358,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 35.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 9.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 330.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | Depreciation | Depreciation | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 18,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.217 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.029 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.001 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.027 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 7.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -559,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 18,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 71,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-350370 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 37.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 600,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -130.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 51.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -49.73M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 4.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 45,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 350,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 80,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 6.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -7.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -210,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | -2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InterestExpense | Interest Expense | USD | 4.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 5.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 5.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 2.17M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-350370 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 3.67M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-350370 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 10.96M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-01 | 0000950170-23-057424 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 3.07M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-01 | 0000950170-23-057424 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 1.89M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.89M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.89M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 39,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | Liabilities | Liabilities | USD | 76.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 95.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 23.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 53.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 60.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 58.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 53.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 165.43M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 9.85M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | NetAssetValuePerShare | Net Asset Value Per Share | USD/shares | 1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 22.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -119.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -130.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -2.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 128.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -128.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.23M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 267,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.72M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 234,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.1 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 697,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 66,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -23,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 44,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 3.83M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091737 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 1.63M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091737 | |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 3.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 445,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 200,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | PreferredStockValueOutstanding | Preferred Stock, Value, Outstanding | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 9.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 232.56M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 810,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 112.22M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | ProceedsFromLongTermLinesOfCredit | Proceeds from Long-term Lines of Credit | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 36.58M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054448 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 517,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 239,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1.61M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -130.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 227,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 25,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-350370 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 90.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211825 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 147.07M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211825 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.21M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.32B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 20.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.959 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.876 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.038 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 18.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.127 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125437 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 598,000 | 2024-04-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091737 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 1.99M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 239,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 226.52M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 33,000 | 2024-07-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269446 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 517,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 843.69M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 856.76M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 50.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 | |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 1.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 10.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 358,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 97,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-07 | 0000950170-24-027927 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 65.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 100,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0000950170-25-030401 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 184.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 184.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462194 |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 447,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130388 |